Innovative approaches to the management of recurrent atrial fibrillation, aortic dilation, and Brugada syndrome.

The European Heart Journal presents innovative approaches to managing recurrent atrial fibrillation, aortic dilation, and Brugada syndrome. Articles discuss the role of diet in preventing cardiovascular diseases, the use of induced pluripotent stem cells in cardiovascular drug development, and the application of artificial intelligence in clinical medicine. A clinical trial in China shows that the traditional Chinese medicine SSYX reduces recurrent atrial tachyarrhythmias post-catheter ablation. Another study introduces the AORTA Gene score for detecting and stratifying ascending aortic dilation. Additionally, research reveals the presence of anti-NaV1.5 autoantibodies in Brugada syndrome patients, suggesting an immunopathogenic component beyond genetic factors. The articles aim to advance precision medicine in cardiovascular care. [Extracted from the article]